These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 19106639)

  • 1. cAMP and Pyk2 interact to regulate prostate cell proliferation and function.
    Kisslinger A; Cantile M; Sparaneo G; Vitale N; Fabbrocini G; Chieffi P; Cillo C; Mancini FP; Tramontano D
    Cancer Biol Ther; 2009 Feb; 8(3):236-42. PubMed ID: 19106639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Convergent Effects of Resveratrol and PYK2 on Prostate Cells.
    Conte A; Kisslinger A; Procaccini C; Paladino S; Oliviero O; de Amicis F; Faicchia D; Fasano D; Caputo M; Matarese G; Pierantoni GM; Tramontano D
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proline-rich tyrosine kinase 2 regulates proliferation and differentiation of prostate cells.
    Picascia A; Stanzione R; Chieffi P; Kisslinger A; Dikic I; Tramontano D
    Mol Cell Endocrinol; 2002 Jan; 186(1):81-7. PubMed ID: 11850124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.
    Rossi V; Bellastella G; De Rosa C; Abbondanza C; Visconti D; Maione L; Chieffi P; Della Ragione F; Prezioso D; De Bellis A; Bellastella A; Sinisi AA
    J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PYK2 via S6K1 regulates the function of androgen receptors and the growth of prostate cancer cells.
    Hsiao YH; Huang YT; Hung CY; Kuo TC; Luo FJ; Yuan TC
    Endocr Relat Cancer; 2016 Aug; 23(8):651-63. PubMed ID: 27492635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative phosphoproteomics reveals the protein tyrosine kinase Pyk2 as a central effector of olfactory receptor signaling in prostate cancer cells.
    Wiese H; Gelis L; Wiese S; Reichenbach C; Jovancevic N; Osterloh M; Meyer HE; Neuhaus EM; Hatt HH; Radziwill G; Warscheid B
    Biochim Biophys Acta; 2015 Jun; 1854(6):632-40. PubMed ID: 25219547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RhoC promotes metastasis via activation of the Pyk2 pathway in prostate cancer.
    Iiizumi M; Bandyopadhyay S; Pai SK; Watabe M; Hirota S; Hosobe S; Tsukada T; Miura K; Saito K; Furuta E; Liu W; Xing F; Okuda H; Kobayashi A; Watabe K
    Cancer Res; 2008 Sep; 68(18):7613-20. PubMed ID: 18794150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of proline-rich tyrosine kinase 2 function induces spreading and motility of epithelial prostate cells.
    de Amicis F; Lanzino M; Kisslinger A; Calì G; Chieffi P; Andò S; Mancini FP; Tramontano D
    J Cell Physiol; 2006 Oct; 209(1):74-80. PubMed ID: 16783820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of Pyk2 and PTP-PEST with leupaxin in prostate cancer cells.
    Sahu SN; Nunez S; Bai G; Gupta A
    Am J Physiol Cell Physiol; 2007 Jun; 292(6):C2288-96. PubMed ID: 17329398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periodic Mechanical Stress INDUCES Chondrocyte Proliferation and Matrix Synthesis via CaMKII-Mediated Pyk2 Signaling.
    Liang W; Li Z; Wang Z; Zhou J; Song H; Xu S; Cui W; Wang Q; Chen Z; Liu F; Fan W
    Cell Physiol Biochem; 2017; 42(1):383-396. PubMed ID: 28558386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cAMP induced modifications of HOX D gene expression in prostate cells allow the identification of a chromosomal area involved in vivo with neuroendocrine differentiation of human advanced prostate cancers.
    Cantile M; Kisslinger A; Cindolo L; Schiavo G; D'Antò V; Franco R; Altieri V; Gallo A; Villacci A; Tramontano D; Cillo C
    J Cell Physiol; 2005 Nov; 205(2):202-10. PubMed ID: 15895411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of all-trans-retinoic acid (RA) on Erk1/2 phosphorylation and cAMP accumulation in normal and malignant human prostate epithelial cells: Erk1/2 inhibition restores RA-induced decrease of cell growth in malignant prostate cells.
    Pasquali D; Chieffi P; Deery WJ; Nicoletti G; Bellastella A; Sinisi AA
    Eur J Endocrinol; 2005 Apr; 152(4):663-9. PubMed ID: 15817924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of proline-rich tyrosine kinase 2 is associated with poor survival of hepatocellular carcinoma via regulating phosphatidylinositol 3-kinase/AKT pathway.
    Cao J; Chen Y; Fu J; Qian YW; Ren YB; Su B; Luo T; Dai RY; Huang L; Yan JJ; Wu MC; Yan YQ; Wang HY
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S312-23. PubMed ID: 22618716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyk2 and Cyr61 at the cross-road of cAMP-dependent signalling in invasiveness and neuroendocrine differentiation of prostate cancer.
    Vitale G; Gentilini D; Abbruzzese A; Caraglia M
    Cancer Biol Ther; 2009 Feb; 8(3):243-4. PubMed ID: 19182531
    [No Abstract]   [Full Text] [Related]  

  • 15. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
    Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
    Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
    Sun CK; Man K; Ng KT; Ho JW; Lim ZX; Cheng Q; Lo CM; Poon RT; Fan ST
    Carcinogenesis; 2008 Nov; 29(11):2096-105. PubMed ID: 18765415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines.
    Dizeyi N; Hedlund P; Bjartell A; Tinzl M; Austild-Taskén K; Abrahamsson PA
    Urol Oncol; 2011; 29(4):436-45. PubMed ID: 19926313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SDF-1 controls pituitary cell proliferation through the activation of ERK1/2 and the Ca2+-dependent, cytosolic tyrosine kinase Pyk2.
    Massa A; Casagrande S; Bajetto A; Porcile C; Barbieri F; Thellung S; Arena S; Pattarozzi A; Gatti M; Corsaro A; Robello M; Schettini G; Florio T
    Ann N Y Acad Sci; 2006 Dec; 1090():385-98. PubMed ID: 17384283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gax inhibits perivascular preadipocyte biofunction mediated by IGF-1 induced FAK/Pyk2 and ERK2 cooperative pathways.
    Liu P; Feng J; Kong F; Lu Q; Xu H; Meng J; Jiang Y
    Cell Signal; 2014 Dec; 26(12):3036-45. PubMed ID: 25280940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
    Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
    Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.